IMMUNOTHERAPY FOR CANCER

An antibody-drug conjugate (ADC) comprising an anti-human SEMA4A humanised or human antibody, a linker and a cytotoxin. L'invention concerne un conjugué anticorps-médicament (ADC) comprenant un anticorps humanisé ou humain anti-SEMA4A humain, un lieur et une cytotoxine.

Saved in:
Bibliographic Details
Main Authors GROVES, MARIA, ADDYMAN, ALEXANDRA, JENKINSON, LESLEY, CHAN, DENICE TSZ YAU, HAYNES, STUART, CHAPMAN, MICHAEL, LAPOINTE, JEAN-MARTIN, MARTIN, KIRSTY-JANE, VAUGHAN, TRISTAN, AUSTIN, MARK, BARNARD, MICHELLE, SLATER, LOUISE, ANDERSON, GEORGINA, DIAMANDAKIS, AGATA, HAWTHORNE, WILLIAM
Format Patent
LanguageEnglish
French
Published 15.06.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:An antibody-drug conjugate (ADC) comprising an anti-human SEMA4A humanised or human antibody, a linker and a cytotoxin. L'invention concerne un conjugué anticorps-médicament (ADC) comprenant un anticorps humanisé ou humain anti-SEMA4A humain, un lieur et une cytotoxine.
Bibliography:Application Number: CA20223240598